Real-time enrollment status for this candida infection clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 10:45 AM UTC
| NCT Number | NCT05421858 |
| Recruiting Status | Recruiting |
| Condition | Candida infection |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Basilea Pharmaceutica |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of July 20, 2026: Clinical trial NCT05421858 is currently recruiting participants. This phase3 study for candida infection is actively seeking new participants at 23 locations across the United States. The study is sponsored by Basilea Pharmaceutica. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05421858 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05421858 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.